NCT05152784View on ClinicalTrials.gov

The TRAMPOLINE VT Study

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 21, 2022

Primary Completion Date

September 23, 2024

Study Completion Date

September 23, 2024

Conditions
Ventricular Tachycardia
Interventions
DEVICE

Octaray catheter

A high density diagnostic catheter used for substrate and activation mapping.

DEVICE

Standard of care

VT ablation guided by substrate-mapping alone.

Trial Locations (1)

Unknown

St. Bartholomew's Hospital, London

All Listed Sponsors
collaborator

Biosense Webster, Inc.

INDUSTRY

lead

Barts & The London NHS Trust

OTHER